Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-11 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.100 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
TNXP | Tonix Pharmaceuticals | 1.09 | -0.09 | -7.63% | 353.1M |
You can purchase shares of Tonix Pharmaceuticals (NASDAQ: TNXP) through any online brokerage.
Other companies in Tonix Pharmaceuticals’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Kezar Life Sciences (NASDAQ:KZR) and ProQR Therapeutics (NASDAQ:PRQR).
The latest price target for Tonix Pharmaceuticals (NASDAQ: TNXP) was reported by Roth Capital on 2019-04-18. The analyst firm set a price target for 0.00 expecting TNXP to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Tonix Pharmaceuticals (NASDAQ: TNXP) is $1.09 last updated Mon Apr 12 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Tonix Pharmaceuticals.
There is no upcoming split for Tonix Pharmaceuticals.